The Journal of Organic Chemistry
Article
nitrogen heterocycle. The product was isolated via gradient column
chromatography on silica gel with EtOAc/hexanes: white solid (173
mg, 68%); H NMR (400 MHz, CDCl3): δ 8.07 (1H, s), 7.91−7.85
Selectfluor byproducts, namely the DABCO monocation, as it was
also a BF4 salt and had similar properties. The H NMR spectrum
shows the product along with the Selectfluor-derived amine in a
1.0:1.1 ratio.
1
1
(1H, m), 7.50−7.45 (1H, m), 7.36−7.30 (2H, m), 7.07−6.99 (3H,
m), 3.97 (3H, s), 3.93 (3H, s); 13C{1H} NMR (100 MHz, CDCl3): δ
149.9, 148.9, 142.6, 129.3, 123.6, 122.6, 120.5, 116.7, 111.7, 110.3,
108.2, 56.2, 56.1; HRMS (ESI-Orbitrap) m/z [M + H]+ calcd for
4.3.8. 1-(3,4-Dimethoxyphenyl)piperazine (Compound 8). The
amination was run according to the procedure for compound 7. The
DABCO adduct was reduced to a piperazine using a previously
reported procedure.10 After the amination had completed, a solution
of saturated aq Na2S2O3 (10.0 mL) was added to the mixture,
followed by H2O (10.0 mL). The mixture was stirred in the sealed
flask or tube at 100 °C for 12−24 h using a heating mantle with sand.
Upon cooling to room temperature, the reaction mixture was
transferred to a separatory funnel and diluted with DCM (20 mL).
Ethylene diamine (2 mL) was added, followed by 6 M NaOH (6 mL),
and the mixture was shaken. The resulting emulsion was treated with
brine (50 mL), and the organic layer was separated after shaking. The
aqueous layer was re-extracted with DCM (2 × 20 mL), then the
combined organic layers were extracted with 1 M HCl (2 × 20 mL).
Ethylene diamine (6 mL) was added to the combined HCl extracts,
followed by 6 M NaOH (10 mL). The basified aqueous mixture was
then extracted with DCM (3 × 20 mL), and the combined organic
layers were dried with Na2SO4, filtered, and concentrated: yellow oil
(157.8 mg, 71%); spectral data match the previously reported
characterization.23
+
C15H15N2O2 255.1128, found 255.1125.
4.3.2. 1-(3,4-Dimethoxyphenyl)-1H-benzo[d][1,2,3]triazole
(Compound 2). The amination was run according to the general
procedure using 1,2-dimethoxybenzene as the arene substrate and
benzotriazole as the nitrogen heterocycle. The product was isolated
via gradient column chromatography on silica gel with EtOAc/
hexanes: white solid (138 mg, 54%); spectral data match the
previously reported characterization.20
4.3.3. 5-(tert-Butyl)-2-(3,4-dimethoxyphenyl)-2H-tetrazole (Com-
pound 3, Major Isomer). The amination was run according to the
general procedure using 1,2-dimethoxybenzene as the arene substrate
and 5-tBu tetrazole as the nitrogen heterocycle. The product was
isolated via gradient column chromatography on silica gel with
EtOAc/hexanes: white solid (194 mg, 74% for both regioisomers); 1H
NMR (400 MHz, CDCl3): δ 7.65−7.58 (2H, m), 6.93 (1H, d, J = 8.6
Hz), 3.96 (3H, s), 3.92 (3H, s), 1.47 (9H, s); 13C{1H} NMR (100
MHz, CDCl3): δ 174.3, 149.7, 149.4, 130.6, 112.1, 111.0, 103.6, 56.2,
56.1, 31.6, 29.5; HRMS (ESI-Orbitrap) m/z [M + H]+ calcd for
4.3.9. 1-(2,5-Dimethoxyphenyl)-1H-benzo[d]imidazole (Com-
pound 9). The amination was run according to the general procedure
using 1,4-dimethoxybenzene as the arene substrate and benzimidazole
as the nitrogen heterocycle. The product was isolated via gradient
column chromatography on silica gel with EtOAc/hexanes: white
+
C13H19N4O2 263.1503, found 263.1502.
4.3.4. 1-(3,4-Dimethoxyphenyl)-1H-imidazole (Compound 4).
The amination was run according to the general procedure using
1,2-dimethoxybenzene as the arene substrate and imidazole as the
nitrogen heterocycle using the following modifications: 4.0 equiv of
imidazole, 4.0 equiv NaHCO3, and 3.5 equiv of Selectfluor. The
product was isolated via gradient column chromatography on silica gel
with EtOAc/hexanes: white solid (84 mg, 41%); spectral data match
the previously reported characterization.21
1
solid (142 mg, 56%); H NMR (400 MHz, CDCl3): δ 8.09 (1H, s),
7.88−7.85 (1H, m), 7.37−7.29 (3H, m), 7.06 (1H, d, J = 8.9 Hz),
7.02−6.96 (2H, m), 3.82 (3H, s), 3.74 (3H, s); 13C{1H} NMR (100
MHz, CDCl3): δ 153.7, 148.0, 143.8, 143.3, 134.2, 125.3, 123.3,
122.4, 120.3, 114.2, 113.6, 113.1, 110.7, 56.3, 55.9; HRMS (ESI-
+
Orbitrap) m/z [M + H]+ calcd for C15H15N2O2 255.1128, found
4.3.5. 4,5-Dibromo-1-(3,4-dimethoxyphenyl)-2-methyl-1H-imi-
dazole (Compound 5). The amination was run according to the
general procedure using 1,2-dimethoxybenzene as the arene substrate
and 4,5-dibromo-2-methylimidazole as the nitrogen heterocycle. The
product was isolated via gradient column chromatography on silica gel
255.1129.
4.3.10. 1-(3,4,5-Triethoxyphenyl)-1H-benzo[d]imidazole (Com-
pound 10). The amination was run according to the general
procedure using 1,2,3-triethoxybenzene24 as the arene substrate and
benzimidazole as the nitrogen heterocycle. The product was isolated
via gradient column chromatography on silica gel with EtOAc/
hexanes: white solid (232 mg, 71%); 1H NMR (400 MHz, CDCl3): δ
8.07 (1H, s), 7.89−7.84 (1H, m), 7.55−7.50 (1H, m), 7.35−7.29
(2H, m), 6.67 (2H, s), 4.16−4.06 (6H, m), 1.46 (6H, t, J = 7.0 Hz),
1.41 (3H, t, J = 7.1 Hz); 13C{1H} NMR (100 MHz, CDCl3): δ 153.8,
143.9, 142.4, 137.6, 133.9, 131.6, 123.6, 122.7, 120.6, 110.5, 103.1,
69.1, 65.0, 15.6, 14.8; HRMS (ESI-Orbitrap) m/z [M + H]+ calcd for
1
with EtOAc/hexanes: white solid (275 mg, 73%); H NMR (400
MHz, CDCl3): δ 6.96 (1H, d, J = 8.5 Hz), 6.82−6.77 (1H, m), 6.69
(1H, d, J = 2.4 Hz), 3.95 (3H, s), 3.89 (3H, s), 2.26 (3H, s); 13C{1H}
NMR (100 MHz, CDCl3): δ 150.0, 149.5, 146.6, 128.4, 120.0, 115.7,
111.0, 110.7, 104.2, 56.2, 56.1, 14.5; HRMS (ESI-Orbitrap) m/z [M
+
+ H]+ calcd for C12H13Br2N2O2 374.9338, found 374.9338.
4.3.6. 2-((1-(3,4-Dimethoxyphenyl)-1H-benzo[d]imidazol-2-yl)-
methyl)isoindoline-1,3-dione (Compound 6). The amination was
run according to the general procedure using 1,2-dimethoxybenzene
as the arene substrate and 2-methylphthalimidobenzimidazole22 as the
nitrogen heterocycle. The product was isolated via gradient column
chromatography on silica gel with EtOAc/hexanes: white solid (322
mg, 78%); 1H NMR (400 MHz, CDCl3): δ 7.85−7.81 (2H, m),
7.76−7.70 (3H, m), 7.28−7.19 (2H, m), 7.13−7.09 (1H, m), 7.06−
7.02 (1H, m), 7.00−6.93 (2H, m), 5.04 (2H, s), 3.93 (3H, s), 3.87
(3H, s); 13C{1H} NMR (100 MHz, CDCl3): δ 167.5, 149.8, 149.6,
148.6, 137.1, 134.1, 132.1, 127.8, 123.5, 123.2, 122.6, 119.8, 119.7,
111.4, 110.6, 110.1, 56.1, 56.1, 34.9; HRMS (ESI-Orbitrap) m/z [M
+
C19H23N2O3 327.1703, found 327.1703.
4.3.11. N-(5-(1H-Benzo[d]imidazol-1-yl)-2,3-dimethoxybenzyl)-
acetamide (Compound 11). The amination was run according to
the general procedure using N-(2,3-dimethoxybenzyl)acetamide as
the arene substrate and benzimidazole as the nitrogen heterocycle.
The product was isolated via gradient column chromatography on
1
silica gel with EtOAc/hexanes: white solid (195 mg, 60%); H NMR
(400 MHz, CDCl3): δ 8.02 (1H, s), 7.86−7.81 (1H, m), 7.50−7.46
(1H, m), 7.34−7.28 (2H, m), 7.03 (1H, d, J = 2.5 Hz), 6.95 (1H, d, J
= 2.5 Hz), 6.37−6.20 (1H, m), 4.51 (2H, d, J = 6.1 Hz), 3.94 (3H, s),
3.90 (3H, s), 2.00 (3H, s); 13C{1H} NMR (100 MHz, CDCl3): δ
170.1, 153.4, 146.5, 143.7, 142.1, 133.7, 133.6, 131.9, 123.6, 122.7,
120.3, 116.5, 110.4, 107.8, 60.7, 56.0, 38.5, 23.1; HRMS (ESI-
+
+ H]+ calcd for C24H20N3O4 414.1448, found 414.1440.
4.3.7. 1-(Chloromethyl)-4-(3,4-dimethoxyphenyl)-1,4-
diazabicyclo[2.2.2]octane-1,4-diium (Compound 7). The amination
was run according to the general procedure with the following
modification: no nitrogen heterocycle was added. The product was
precipitated with the addition of 50% EtOAc in hexane, filtered, and
washed with more EtOAc/hexane. The product was dissolved in
acetone and concentrated to dryness: white hygroscopic solid (448.8
mg, 95%); 1H NMR (400 MHz, CDCl3): δ 7.31−7.26 (2H, m),
7.13−7.09 (1H, m), 5.36 (2H, s), 4.42−4.36 (6H, t, J = 7.3 Hz),
4.16−4.10 (6H, t, J = 7.3 Hz), 3.92 (3H, s), 3.88 (3H, s); HRMS
+
Orbitrap) m/z [M + H]+ calcd for C18H20N3O3 326.1499, found
326.1499.
4.3.12. 1-(6,7,9,10,17,18,20,21-Octahydrodibenzo[b,k]-
[1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)-1H-benzo[d]-
imidazole (Compound 12). The amination was run according to the
general procedure using dibenzo-18-crown-6 as the arene substrate
and benzimidazole as the nitrogen heterocycle. The product was
isolated via gradient column chromatography on silica gel with DCM/
+
1
(ESI-Orbitrap) m/z [M − BF4]+ calcd for C15H23N2O2ClBF4
hexanes with 1.5% Et3N: white solid (305 mg, 64%); H NMR (400
385.1472, found 385.1465. The product was inseparable from the
MHz, CDCl3): δ 8.03 (1H, s), 7.88−7.84 (1H, m), 7.47−7.42 (1H,
5775
J. Org. Chem. 2021, 86, 5771−5777